Manufacturers participating in CADTH's new time-limited funding mechanism must submit updated clinical trial data within the agreed-upon time or their funding will be terminated and any existing patients will become their responsibility.
Canada is implementing a mechanism for issuing “time-limited” reimbursement recommendations for certain medicines that will be similar to practices other countries use to enable early access to drugs while more evidence is generated to address any uncertainty identified during the initial heath technology assessment.
The temporary funding mechanism will be introduced in the autumn by Canadian heath technology assessment (HTA) agency CADTH, according to the pan-Canadian Pharmaceutical Alliance,
Industry will fight hard to prevent other states or the federal government from adopting measures similar to Arkansas' law preventing PBMs from owning pharmacies.
A former CMS official suggested the most likely way it could happen is through a Center for Medicare and Medicaid Innovation demonstration.
New CBER Director Prasad will "unleash a massive" framework on vaccines, FDA Commissioner Marty Makary said 15 May, raising questions about the impact on products nearing approval.
